Sustainability in Healthcare, Pharma & Life Sciences

Sustainability in Healthcare

The healthcare sector is facing rapid disruptive change as sustainability criteria and worldwide health issues come to the fore. As the world begins to face up to novel medical challenges and opportunities, healthcare organisations need to keep pace with these changes and adapt.

Global pandemics from ebola to COVID-19 challenge the sector to work at a scale of collaboration and speed never before achieved. COVID-19 highlighted our vulnerabilities, but also our capacity to adapt and innovate to not only solve global crises, but to additionally harness such circumstances to transition to more sustainable practices.

Driving Sustainable Change in Healthcare & Life Sciences

As sustainability agendas become increasingly mainstream across industries, we’ve seen many healthcare organisations rise to the opportunity with an understanding that the sector has the ability to profoundly influence a healthier, happier and more sustainable future for all. Many signs of positive change in the healthcare industry are already in motion, including:

• Financial models evolving to include rapid healthcare payer and provider consolidations
• Medical insurance system transformations & regulatory developments aimed at reducing costs and increasing access
• Digitisation offering revolutionary opportunities to improve access, health equity, and the quality of care

Innovation is at the core of how the healthcare sector becomes more sustainable:  innovation in technologies, medicines and techniques for healing, for delivering care, and for managing information. Harnessing such technologies creates a powerful driver for sustainability, as seen in the rise of on-demand healthcare and powerful technological innovations ranging from big data utilisation, VR to treat patients, medical wearables, predictive healthcare & AI and blockchain technologies.

Supporting a healthier, more sustainable future

As a sector inherently invested in bringing health and wellness to communities and families, the missions of healthcare and life science organisations are greatly impacted by the need to address the biggest challenges to sustainability. On top of that, designing and delivering medical care optimised for sustainability promises to:

• reduce costs
• mitigate risks
• strengthen relationships throughout the supply chain
• build resiliency in the face of regulatory and commercial changes.
• support preventative care in support of population and public health.

Increasingly hospitals and markets are seeking greener, safer chemistries and healthier, more sustainable products. The demand is coming from patients, clinical customers, non-clinical customers, investors, employees, and other stakeholders. Group Purchasing Organizations (GPOs) have expanded the application of Environmentally Preferable Purchasing (EPP) mandates, typically demanding information on product circularity, waste and green chemistry.

As such, stakeholders in industries ranging from pharmaceuticals, medical equipment, healthcare delivery, biotechnology and everything in between are embedding the understanding of the connections between environmental sustainability, human health and wellbeing and circular, no-waste systems into their business decisions and priorities.

Tools to support the Healthcare & Life Sciences sector

Anthesis further supports the healthcare, pharmaceuticals, and life sciences sector through the development and implementation of custom tools to leverage leading technology solutions.

Our tools and technologies suit a variety of environmental and sustainability agendas, including energy systems, water, carbon and product compliance, for hospitals, labs and elsewhere.

• RiskHorizon – The purpose made tool helps legal advisors, investors, finance professionals and deal makers to identify the material ESG risks and opportunities at an early stage of the deal cycle and take full account of the relevant issues throughout the transaction life cycle.
• Footprinter – Footprinter, is the leading technology platform for enterprise sustainability.
• Anthesis Compliance Data Collection (ACDC) – ACDC, our IPC-1752A compliant data collection tool, is used by our clients’ supply chains to create FMD declarations and to capture lab reports.
• CleanCO2 – a carbon management tool that allows companies and events to calculate, offset and reduce their carbon footprint. It accompanies users throughout the process of neutralizing their company’s activities and greenhouse gas emissions, helping them to achieve carbon neutrality by investing in projects to reduce emissions, such as energy efficiency, renewable energies, and carbon sinks.
• Tennaxia – Digital platform for companies to collect and manage extra-financial data.

LEARN MORE ABOUT ANTHESIS TECHNOLOGIES

Contact us

Find out how we can support you